Serum C-reactive protein parallels secretory phospholipase A2 in sickle cell disease patients with vasoocclusive crisis or acute chest syndrome [4]

Blood

Volumn 105, Issue 8, 2005, Pages 3384-3385

  Bargoma, Emilee M ^b   Mitsuyoshi, Joyce K ^b   Larkin, Sandra K ^b   Styles, Lori A ^b   Kuypers, Frans A ^b   Test, Samuel T ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PHOSPHOLIPASE A2;

ACUTE CHEST SYNDROME; BLOOD SAMPLING; BLOOD VESSEL OCCLUSION; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME ASSAY; FLUOROMETRY; HOSPITALIZATION; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SICKLE CELL ANEMIA;

EID: 17044429065     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-12-4676     Document Type: Letter

References (8)

1. 2 levels in acute chest syndrome of sickle cell disease. Blood. 1996;87:2573-2578.
2. 2 predicts impending acute chest syndrome in sickle cell disease. Blood. 2000;96:3276-3278.
3. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-454.
4. 2 in human serum. Clin Chem. 1992;38:1824-1829.
5. Wolbink G-J, Bossink AW, Groeneveld AJ, de Groot MC, Thijs LG, Hack CE. Complement activation in patients with sepsis is in part mediated by C-reactive protein. J Infect Dis. 1998;177:81-87.
6. Aziz N, Fahey JL, Detels R, Butch AW. Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood. Clin Diagn Lab Immunol. 2003;10:652-657.
7. 2 activity correlates with postinjury multiple organ failure. Crit Care Med. 2001;29:989-993.
8. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805-1812.